Asia leveraged finance: Institutional aspirations
PE firms can obtain financing for leveraged buyouts in Asia on increasingly favorable terms, but this doesn’t necessarily point to institutionalization – or at least, not yet. For now, banks still lead the way
Australia’s leveraged buyout market changed comprehensively – and perhaps permanently – last summer when Pacific Equity Partners and The Carlyle Group acquired iNova Pharmaceuticals for $930 million....
More on Financing
Latest News
PE investors wary of inflation in 2022 - AVCJ Forum
Inflation is top of mind for Asia-focused private equity investors as they assess the various uncertainties facing the industry in 2022, the AVCJ Private Equity & Venture Forum heard.
Legend hits first close on healthcare fund, launches TMT vehicle
Legend Capital has reached a first close of $177 million on its third US dollar-denominated China healthcare fund. It is one of five vehicles the GP has in the market, including its recently launched ninth flagship technology, media, and telecom (TMT)...
Qiming leads $40m round for Allorion Therapeutics
China and US-based precision medicine company Allorion Therapeutics has raised a $40 million Series A round led by Qiming Venture Partners.
Japan space debris start-up Astroscale gets $109m Series F
Astroscale, a Japanese space tech start-up dedicated to cleaning up orbital debris, has raised $109 million in Series F funding from investors including London-listed Seraphim Space Investment Trust, Japan Growth Capital Investment, and Axa Life Insurance.